Envestnet Asset Management Inc Bio Line Rx Ltd. Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q3 2024
A detailed history of Envestnet Asset Management Inc transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 239,186 shares of BLRX stock, worth $66,972. This represents 0.0% of its overall portfolio holdings.
Number of Shares
239,186
Previous 213,833
11.86%
Holding current value
$66,972
Previous $121,000
6.61%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BLRX
# of Institutions
38Shares Held
3.35MCall Options Held
46.5KPut Options Held
6.3K-
Alyeska Investment Group, L.P. Chicago, IL866KShares$242,6180.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE816KShares$228,3914.05% of portfolio
-
Morgan Stanley New York, NY198KShares$55,3100.0% of portfolio
-
Values First Advisors, Inc.198KShares$55,3040.06% of portfolio
-
Pvg Asset Management Corp Golden, CO157KShares$44,0200.37% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $17.2M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...